These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9524574)

  • 1. Teratocarcinomas and human embryology: pluripotent human EC cell lines. Review article.
    Andrews PW
    APMIS; 1998 Jan; 106(1):158-67; discussion 167-8. PubMed ID: 9524574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
    Wakeman JA; Walsh J; Andrews PW
    Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular teratocarcinogenesis in mice--a review.
    Matin A; Collin GB; Varnum DS; Nadeau JH
    APMIS; 1998 Jan; 106(1):174-82. PubMed ID: 9524576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell.
    Walsh J; Andrews PW
    APMIS; 2003 Jan; 111(1):197-210; discussion 210-1. PubMed ID: 12760378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CDK inhibitor p27 enhances neural differentiation in pluripotent NTERA2 human EC cells, but does not permit differentiation of 2102Ep nullipotent human EC cells.
    Bahrami AR; Matin MM; Andrews PW
    Mech Dev; 2005 Sep; 122(9):1034-42. PubMed ID: 16023837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachyury is expressed by human teratocarcinoma cells in the absence of mesodermal differentiation.
    Gokhale PJ; Giesberts AM; Andrews PW
    Cell Growth Differ; 2000 Mar; 11(3):157-62. PubMed ID: 10768863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
    Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
    Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
    Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
    Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrids of pluripotent and nullipotent human embryonal carcinoma cells: partial retention of a pluripotent phenotype.
    Duran C; Talley PJ; Walsh J; Pigott C; Morton IE; Andrews PW
    Int J Cancer; 2001 Aug; 93(3):324-32. PubMed ID: 11433395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of human pluripotent teratocarcinoma stem cells induced by bone morphogenetic protein-2.
    Pera MF; Herszfeld D
    Reprod Fertil Dev; 1998; 10(7-8):551-5. PubMed ID: 10612460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ID gene expression varies with lineage during differentiation of pluripotential male germ cell tumor cell lines.
    Houldsworth J; Reuter VE; Bosl GJ; Chaganti RS
    Cell Tissue Res; 2001 Mar; 303(3):371-9. PubMed ID: 11320653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours.
    Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J
    Int J Cancer; 2000 Feb; 85(3):370-5. PubMed ID: 10652429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene regulation during neuronal and non-neuronal differentiation of NTERA2 human teratocarcinoma-derived stem cells.
    Ackerman SL; Knowles BB; Andrews PW
    Brain Res Mol Brain Res; 1994 Aug; 25(1-2):157-62. PubMed ID: 7984043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput microRNAome analysis in human germ cell tumours.
    Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
    J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cloned human germ cell tumor-derived cell line differentiating in culture.
    Tienari J; Reima I; Larramendy ML; Knuutila S; von Boguslawsky K; Kaartinen M; Virtanen I; Lehtonen E
    Int J Cancer; 1998 Aug; 77(5):710-9. PubMed ID: 9688304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and biology of adult human male germ cell tumors.
    Chaganti RS; Houldsworth J
    Cancer Res; 2000 Mar; 60(6):1475-82. PubMed ID: 10749107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human teratocarcinomas.
    Andrews PW
    Biochim Biophys Acta; 1988 Aug; 948(1):17-36. PubMed ID: 3293662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysine methylation represses p53 activity in teratocarcinoma cancer cells.
    Zhu J; Dou Z; Sammons MA; Levine AJ; Berger SL
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9822-7. PubMed ID: 27535933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-renewal of teratocarcinoma and embryonic stem cells.
    Chambers I; Smith A
    Oncogene; 2004 Sep; 23(43):7150-60. PubMed ID: 15378075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD30 and CD30 ligand in cultured cell lines from human germ-cell tumors.
    Pera MF; Bennett W; Cerretti DP
    Lab Invest; 1997 Apr; 76(4):497-504. PubMed ID: 9111512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.